Skip to content

Sedation Strategies for Therapeutic Bronchoscopy

Comparison of Sedation and General Anesthesia With Laryngeal Mask in Therapeutic Bronchoscopy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03406546
Enrollment
20
Registered
2018-01-23
Start date
2018-02-01
Completion date
2018-07-31
Last updated
2019-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchoscopy, Sedation

Brief summary

Therapeutic bronchoscopy is a common procedure to treat respiratory diseases. The procedure includes stent implantation, bronchus dilation, electronic incision, laser therapy, and so on. Most of these procedures are painful and require general anesthesia. Conventionally, the general anesthesia for therapeutic bronchoscopy was performed using laryngeal mask. But in the previous experiences, the investigators found that sedation with dexmedetomidine and remifentanil was as effect as laryngeal mask anesthesia. The present study was performed to compare the two approach for sedation or anesthesia in therapeutic bronchoscopy.

Interventions

DRUGDexmedetomidine

Dexmedetomidine was used as a sedation agent with less side effect on respiratory system.

DRUGRemifentanil

Remifentanil was used to prevent cough induced by bronchoscopy.

Laryngeal mask was used to ensure respiration function during general anesthesia.

Sponsors

Shanghai Zhongshan Hospital
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
Shanghai Pulmonary Hospital, Shanghai, China
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for flexible therapeutic bronchoscopy * Adult patients aged 18 to 65 years * American Society of Anesthesiologists (ASA) Physical Status Classification I-II * BMI 18.5-25kg/m2 * Subjects provide informed consent

Exclusion criteria

* Severe airway obstruction * Coagulation disorder * Repeat bronchoscopy (more than 3 times) * Severe liver and renal dysfunction * Cardiovascular and cerebrovascular diseases * Pregnancy * Chronic opioid user * Drug abusers or addicts

Design outcomes

Primary

MeasureTime frameDescription
Recovery timeAfter termination of the sedation medication, assessed up to 3 hoursDuration of the recovery from sedation

Secondary

MeasureTime frameDescription
Satisfaction score of the patients and bronchoscopistsAcross the procedure, assessed up to 3 hoursSatisfaction score of the patients and bronchoscopists regarding to the sedation quality measured by a 0-100 visual analogue scale (VAS). 100 refers to the highest satisfaction degree while 0 refers to the worst satisfaction degree.
Prevalence of the side effects of respiratory and circulatory systemAcross the sedation or anesthesia, assessed up to 3 hoursThe number of the side effects in respiratory and circulatory system during the procedure, including hypertension, hypotension, tackycardia, bradycardia, hypoxia and larynx spasm.
Cost of anesthesia or sedationAcross the sedation or anesthesia, assessed up to 3 hours
Cough scoreFrom the completion of local anesthesia with lidocaine to the completion of bronchoscopy procedure, assessed up to 3 hoursCough score across the procedure will be classified into 4 degree (1-4) as follows. 1 = none, 2 = one gag or cough only, 3 = \>1 gag or cough, but acceptable conditions, 4 = unacceptable conditions
The numbers of the times of body movementFrom the completion of local anesthesia with lidocaine to the completion of bronchoscopy procedure, assessed up to 3 hoursThe numbers of the times of any body movement across the procedure

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026